Back to mobile site

BTIG Reiterates Buy Rating on Medline Inc (MDLN)

March 9, 2026 5:20 AM EDT Send to a Friend
BTIG analyst David Larsen reiterated a Buy rating and $55.00 price target on Medline Inc (NASDAQ: MDLN).The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login